GALT
Galectin Therapeutics Inc
3.80$
+1.3%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +32.4% | -57.9% | -9.0% | +0.0% | -17.3% | -4.5% | -23.4% | -24.5% | -67.6% | -25.0% | +0.0% | +33.3% | -16.7% | -30.0% | +0.0% | -85.7% | +0.0% | +3,400.0% | +2.9% | +13.9% | -22.0% | +3.1% | +12.1% | +43.2% | |
| – | – | – | +320.1% | -73.8% | -85.8% | +1,708.7% | +48.1% | +13.1% | +131.0% | +20.6% | +67.1% | -99.9% | +135,609.2% | +7.4% | -16.5% | -27.1% | -55.6% | +303.7% | -62.1% | +6.9% | +15.4% | +38.1% | -21.1% | +8.2% | -32.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | +18.0% | -23.9% | -27.1% | -53.8% | +318.2% | -63.1% | +6.6% | +28.7% | +12.1% | – | – | – | |
| – | +100.1% | -16.9% | -90.3% | +4,503.5% | -50.8% | -238.6% | – | -168.5% | – | -271.2% | – | -142.8% | – | -239.2% | – | – | -131.6% | – | – | +47.0% | +298.2% | +32.4% | -5.8% | -51.2% | -73.3% | |
| – | +1,611.2% | -27.7% | -68.2% | -41.6% | -8.7% | +366.7% | -57.1% | -95.2% | -100.0% | – | – | +0.0% | +0.0% | -100.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1,611.2% | -19.2% | -23.6% | -34.7% | +60.9% | +4,617.1% | – | -99.8% | – | – | – | – | +0.0% | -725.0% | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | +891.9% | -25.9% | -100.0% | – | -3.4% | +0.0% | -21.4% | +66.3% | -25.7% | -56.9% | -65.2% | +24.8% | -43.3% | +23.7% | -24.2% | +51.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | -63.2% | +720.9% | -56.5% | -56.8% | -88.3% | +2,109.6% | +228.2% | -99.5% | -11,506.8% | – | -25.4% | +25.9% | -21.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | +0.0% | +0.0% | -66.7% | +200.0% | +0.0% | -30.0% | |
| – | +985.6% | +9.0% | +180.1% | -4.5% | – | – | -87.0% | +237.8% | +4.5% | +128.8% | -29.1% | +67.9% | -17.2% | +265.5% | -56.5% | -56.8% | -39.5% | +329.2% | +225.6% | -99.5% | +13,897.7% | -72.8% | +300.3% | -22.0% | -15.2% | |
| – | +512.6% | -66.6% | +1,222.3% | -45.6% | -301.5% | – | – | -283.3% | – | – | -91.0% | +486.4% | -62.1% | +1,556.8% | -117.6% | – | – | – | +654.4% | -151.8% | – | -268.4% | – | -249.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.